Bladder Cancer Immunotherapy by BCG is associated with a significantly reduced risk of Alzheimer‘s disease

Danielle Klinger, Brian L. Hill, Noam Barda, Eran Halperin, Ofer N. Gofrit, Charles L. Greenblatt, Nadav Rappoport, Michal Linial, Hervé Bercovier
doi: https://doi.org/10.1101/2021.01.30.21250811

Data Availability

This is a cohort data all statistics are reported in the manuscript and in supplementary data.

Back to top
Posted February 04, 2021.
Download PDF
Data/Code
Email
Bladder Cancer Immunotherapy by BCG is associated with a significantly reduced risk of Alzheimer‘s disease
Danielle Klinger, Brian L. Hill, Noam Barda, Eran Halperin, Ofer N. Gofrit, Charles L. Greenblatt, Nadav Rappoport, Michal Linial, Hervé Bercovier
medRxiv 2021.01.30.21250811; doi: https://doi.org/10.1101/2021.01.30.21250811
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area